CEACAM5 and neoplasm: Tumor biomarkers such as cancer antigens (CA-125, 19.9), carcinoembryonic antigen (CEA), and alpha-phetoprotein (AFP) have been extensively used for other hepatobiliary malignancies, even if they have low specificity [83].